Edition:
United Kingdom

Lantheus Holdings Inc (LNTH.OQ)

LNTH.OQ on NASDAQ Stock Exchange Global Market

15.65USD
21 Sep 2018
Change (% chg)

$-0.55 (-3.40%)
Prev Close
$16.20
Open
$16.20
Day's High
$16.27
Day's Low
$15.55
Volume
1,048,420
Avg. Vol
91,363
52-wk High
$24.45
52-wk Low
$12.85

Latest Key Developments (Source: Significant Developments)

Lantheus Holdings Appoints Robert J. Marshall, Jr. As CFO
Monday, 20 Aug 2018 

Aug 20 (Reuters) - Lantheus Holdings Inc ::LANTHEUS HOLDINGS APPOINTS ROBERT J. MARSHALL, JR. AS CHIEF FINANCIAL OFFICER AND TREASURER.LANTHEUS HOLDINGS INC - APPOINTED ROBERT MARSHALL, AS CHIEF FINANCIAL OFFICER AND TREASURER, EFFECTIVE SEPTEMBER 24, 2018.LANTHEUS HOLDINGS - MARSHALL SUCCEEDS JACK CROWLEY.LANTHEUS HOLDINGS INC - PRIOR TO JOINING CO, MARSHALL SPENT 16 YEARS WITH ZIMMER BIOMET HOLDINGS.  Full Article

Lantheus Holdings Q2 Earnings Per Share $0.25
Wednesday, 1 Aug 2018 

Aug 1 (Reuters) - Lantheus Holdings Inc ::LANTHEUS HOLDINGS, INC. REPORTS 2018 SECOND QUARTER RESULTS.Q2 EARNINGS PER SHARE $0.25.Q2 EARNINGS PER SHARE VIEW $0.22 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 REVENUE ABOUT $337 MILLION TO $342 MILLION.SEES Q3 2018 REVENUE $82 MILLION TO $86 MILLION.Q2 REVENUE $85.6 MILLION VERSUS I/B/E/S VIEW $87.9 MILLION.  Full Article

Lantheus Holdings Says Lantheus Medical Entered Extension Of Supply Agreement With Jubilant Drax Images​
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Lantheus Holdings Inc ::LANTHEUS HOLDINGS-ON DEC. 30, 2017, LANTHEUS MEDICAL ENTERED BINDING EXTENSION OF SUPPLY AGREEMENT WITH JUBILANT DRAX IMAGES,EFFECTIVE JAN. 1, 2018 ​.LANTHEUS HOLDINGS INC - ‍LMI WILL CONTINUE TO SUPPLY TRIAD WITH TECHNELITE GENERATORS, XENON, NEUROLITE AND OTHER PRODUCTS THROUGH 2020 - SEC FILING​.LANTHEUS HOLDINGS INC - ‍EXTENDED SUPPLY AGREEMENT WILL EXPIRE ON DECEMBER 31, 2020​.  Full Article

Lantheus Holdings reports Q3 earnings per share $0.22
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Lantheus Holdings Inc :Lantheus Holdings Inc reports 2017 third quarter financial results; exceeds third quarter and raises full-year 2017 guidance.Q3 earnings per share $0.22.Q3 revenue $79.9 million versus I/B/E/S view $77.3 million.Sees fy 2017 revenue $323 million to $325 million.Q3 earnings per share view $0.21 -- Thomson Reuters I/B/E/S.Lantheus Holdings Inc - ‍increased its full-year 2017 guidance range for adjusted EBITDA to $86 million to $88 million from previous guidance of $82 million to $85 million​.Lantheus Holdings Inc - fy guidance for both revenue and adjusted EBITDA excludes impact of a $5.0 million up-front payment received in q2 of 2017 from GE Healthcare​.  Full Article